Most of this team looks like they're more interested in policy than pharmaceuticals. Baldwin Way's research focus may put him in more contact with pharma: http

Most of this team looks like they're more interested in policy than pharmaceuticals. Baldwin Way's research focus may put him in more contact with pharma: https://psychology.osu.edu/people/way.37 https://psychology.osu.edu/people/way.37 His R01 is looking at substance abuse: https://reporter.nih.gov/project-details/10304875 https://reporter.nih.gov/project-details/10304875